roche - Search News

Roche, Zealand and obesity

Reuters on MSN · 19h

Roche secures Zealand obesity drug candidate for up to $5.3 billion

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, as the Swiss drugmaker seeks to boost its prospects in the booming weight-loss market.

Pharmalittle: We’re reading about a Roche deal for an obesity drug, a Gilead HIV drug and more

Germany's financial markets watchdog is looking at whether Bayer fairly disclosed plans for shareholder approval of a capital increase.

BioPharma Dive · 16h

Roche broadens obesity drug plans with $1.65B Zealand deal

The deal gives the Swiss pharma access to an experimental amylin-targeting treatment it will test in combination with drugs it acquired from Carmot.

Proactiv, La Roche-Posay and recall

La Roche-Posay, Walgreens, Proactiv and More Voluntarily Recall Acne Treatments Due to Trace Amounts of Cancer-causing Benzene

La Roche-Posay, Walgreens, Proactiv and SLMD Skincare have voluntarily recalled acne treatments from retail that contained trace amounts of the cancer-causing ingredient benzene.

NBC Chicago · 16h

La Roche-Posay, Proactiv products recalled over levels of cancer-causing chemical

Face care products from several popular brands are being recalled over elevated levels of a cancer-causing ingredient.

cleveland.com on MSN · 8h

Cancer-causing chemical leads popular company to recall skin product

The recall comes in the wake of concerns over contamination of benzene, news outlet reported. A spokesperson for La Roche-Posay wrote in a statement to cleveland.com and The Plain Dealer that product safety is the company’s highest priority.

16hon MSN

Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

Roche Absorbs $2.4B Impairment in Overhaul of Spark Gene Therapy Unit

In connection with Spark’s overhaul, Roche will incur approximately $2.4 billion in goodwill impairment costs. This sum takes ...

5d

Roche to open innovation center at new Harvard campus in Allston that could employ hundreds

Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise ...

Fierce Biotech23h

Roche pads out obesity pipeline, paying Zealand $1.6B upfront to codevelop amylin asset

Roche is paying $1.65 billion in confirmed upfront fees to add to its burgeoning obesity pipelin | Roche is paying $1.65 ...

18hon MSN

Roche Targets Weight-Loss Drug Market Dominated by Novo Nordisk, Eli Lilly

Key Takeaways Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly.The Swiss ...

21hon MSN

Health Care Roundup: Market Talk

Find insight on Roche, Novo Nordisk, Tricare and more in the latest Market Talks covering Health Care.

22h

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Q32 Bio (QTTB)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF – Research Report) ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results